Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11527 posts found.

Higher dose of Glivec not cost effective, says NICE

June 29, 2010 Sales and Marketing Glivec, NICE, gastric cancer

 
News

Digital Pharma: The smokescreen of regulation

June 28, 2010 Medical Communications, Sales and Marketing Janssen, social media

When framing a story for the media it is well known in the communications community that a successful piece must …
Feature

European regulator probes ARB cancer link

June 28, 2010 Sales and Marketing ARB, Amias, Aprovel, Cozaar, Diovan, Micardis

European regulators have begun an investigation into a possible risk of cancer in patients taking angiotensin II receptor inhibitors for …
News

Shire’s Vpriv recommended for European approval

June 28, 2010 Sales and Marketing Brinavess, Gaucher, Rapiscan, Ruconest, Shire, Sycrest

Shire has won backing from a key European regulatory committee for its new Gaucher disease orphan drug. Vpriv was one …
News

Actavis appoints Dr Claudio Albrecht

June 28, 2010 Sales and Marketing Actavis, appointment, sales and marketing

Icelandic generics company Actavis has appointed Dr Claudio Albrecht as its new chief executive. He formerly led Ratiopharm and has …
Appointment

New anti-clotting drugs: stopping the silent killers

June 28, 2010 Research and Development, Sales and Marketing Pradaxa, VTE, Xarelto, atrial fibrilation, thrombosis

Blood clots are a major killer, but the threat they pose is poorly understood by the general public compared to …
Feature

Langland and Dr Foster share top honours at Best of Health

June 25, 2010 Medical Communications, Sales and Marketing Best of Health, IPA, awards

Dr Foster Intelligence and Langland were awarded the most prestigious ‘Best of Show’ awards at the 2010 IPA Best of …
News

Sanofi licences novel oral anti-diabetic treatment

June 25, 2010 Research and Development, Sales and Marketing Metabolex, Sanofi-Aventis, diabetes

Sanofi-Aventis has signed an exclusive worldwide licensing agreement with US-based diabetes specialist Metabolex for a novel oral anti-diabetic treatment. MBX-2982 …
News

NICE re-thinks arthritis guidance

June 25, 2010 Sales and Marketing Enbrel, Humira, MabThera, NICE, Orencia, Remicade, TNF, rheumatoid arthritis

NICE has approved five rheumatoid arthritis treatments in certain circumstances after treatment with a tumour necrosis factor inhibitor has failed. …
News

Digital Pharma: First pharma iPad apps

June 25, 2010 Medical Communications, Sales and Marketing Apple, Pfizer, Sanofi, app, ipad, iphone

The first big pharma apps specially designed for Apple’s iPad have started to emerge, with Pfizer and Sanofi leading the …
News

NICE rejects Glivec as adjuvant therapy

June 24, 2010 Sales and Marketing Glivec, NICE, Novartis

NICE has rejected the use of Novartis’ Glivec as an adjuvant treatment for people who have had a gastrointestinal stromal …
News

Mixed reaction for Osborne’s first Budget

June 23, 2010 Research and Development, Sales and Marketing biotech, pharma, tax, tax relief

George Osborne’s first Budget as chancellor has had a mixed reception from the pharma and biotech sectors. The BioIndustry Association …
News

Pfizer withdraws blood cancer drug in US

June 22, 2010 Sales and Marketing AML, Mylotarg, Pfizer, blood cancer

The US regulatory body has withdrawn Pfizer’s leukaemia drug Mylotarg after it was linked to a number of deaths, and …
News

NDA appoints Dr Panos Tsintis

June 22, 2010 Sales and Marketing NDA, appointment, sales and marketing

European regulatory affairs consulting group NDA has appointed Dr Panos Tsintis medical advisor to NDA Regulatory Science in a move …
Appointment

Let’s avoid further stand-offs, says Witty

June 22, 2010 Research and Development, Sales and Marketing EFPIA, Greece, industry, pricing

Pharma will need to find new ways of working with European governments in order to avoid further crises as witnessed …
News
The Gateway to Local Adoption Series

Latest content

Scots neonatal innovations target hearing loss and earlier care

August 28, 2026

FDA grants De Novo authorisation to light-filtering device for migraine

August 28, 2026

Southgate opens Innovation Lab for logistics and fulfilment development

August 27, 2026

Bioptimus partners with Cancer Research Horizons to expand AI cancer data set

August 27, 2026

Agentis Health Group acquires Clinical Pharmacist Solutions

August 26, 2026